Morrisons launches weight loss jab subscription service

The supermarket's new service aims to assist shoppers in significant weight loss.

Morrisons introduces subscription for weight loss injections

Morrisons has launched a monthly subscription service for tirzepatide injections, also known as Mounjaro, aimed at helping customers lose weight. Priced at £129 per month, this treatment claims potential weight loss of up to 20% of a user's body weight within a year. The service includes a medical history assessment and ongoing monitoring by pharmacists to ensure safety. However, customers have criticized the supermarket for offering weight loss solutions while simultaneously selling unhealthy food options.

Morrisons' new offering raises ethical questions about promoting health while contributing to unhealthy eating habits. Critics argue that the supermarket's strategy is hypocritical, as it profits from unhealthy products while offering a costly solution for weight management. As public awareness of health issues grows, the response to such contradictions could influence customer loyalty and brand perception. This scenario reflects broader societal tensions between consumption practices and health priorities.

Highlights

The reception of this service could impact Morrisons' image in the health and retail sectors.